title: Anti-CD20 antibody (Rituximab) therapy in a myasthenia gravis patient with follicular lymphoma.
authors.forename: Kazutaka
authors.initials: K
authors.lastname: Takagi
authors.forename: Akira
authors.initials: A
authors.lastname: Yoshida
authors.forename: Hiromichi
authors.initials: H
authors.lastname: Iwasaki
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Inoue
authors.forename: Takanori
authors.initials: T
authors.lastname: Ueda
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies / Q000097:blood / Q000187:drug effects; D005260:Female; D006801:Humans; D008224:Lymphoma, Follicular / Q000150:complications / Q000188:drug therapy*; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000150:complications / Q000188:drug therapy*; D011950:Receptors, Cholinergic / Q000276:immunology; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D011950:Receptors, Cholinergic; D000069283:Rituximab